Effects of arsenic on human keratinocytes: Morphological, physiological, and precursor incorporation studies

被引:15
作者
Bernstam, L [1 ]
Lan, CH [1 ]
Lee, J [1 ]
Nriagu, JO [1 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Environmental Hlth Sci, Ann Arbor, MI 48109 USA
关键词
arsenic; artificial skin; percutaneous absorption; toxicity;
D O I
10.1006/enrs.2002.4367
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Measurement of in vitro percutaneous absorption of As(III) and As(V) by artificial human skin shows a strong affinity of arsenic for the human keratinocytes, with 1-10% of the applied arsenic dose retained by the artificial skin per hour. The inordinate retention of arsenic by the skin is a risk factor for As toxicity. The calculated permeability constant (K-p) averaged about 4.3x10(-5)cm/h for As(V) and 10.1x10(-5)cm/h for As(III). A facile calculation suggests that dermal absorption during showering and hand washing can be an important exposure route if the water contains more than 100 mug/L As(III) or As(V). The effects of the absorbed arsenic in artificial skin were evaluated in terms of morphological characteristics, integrity of the cell membrane (by means of lactate dehydrogenase and MTS assays), and rates of DNA, RNA, and protein synthesis estimated by incorporation of radioactive precursors. We found significant morphological changes, cytotoxicity associated with disruption of the cell membrane, and inhibition of DNA and protein syntheses at As(III) exposure doses as low as 10 mug/L. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:220 / 235
页数:16
相关论文
共 65 条
[1]   Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT [J].
Abe, K ;
Matsuki, N .
NEUROSCIENCE RESEARCH, 2000, 38 (04) :325-329
[2]  
ATSDR, 1999, TOX PROF ARS
[3]   ARSENIC INGESTION AND INTERNAL CANCERS - A REVIEW [J].
BATES, MN ;
SMITH, AH ;
HOPENHAYNRICH, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (05) :462-476
[4]   Molecular aspects of arsenic stress [J].
Bernstam, L ;
Nriagu, J .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2000, 3 (04) :293-322
[5]  
BERNSTAM L, 2000, 11 ANN I C HEAV MET, P1026
[6]  
BERNSTAM L I, 1990, Journal of Dermatological Science, V1, P173, DOI 10.1016/0923-1811(90)90129-2
[7]  
BERNSTAM LI, 1986, IN VITRO CELL DEV B, V22, P695
[8]   CELLULAR UPTAKE AND METABOLIC REDUCTION OF PENTAVALENT TO TRIVALENT ARSENIC AS DETERMINANTS OF CYTOTOXICITY AND MORPHOLOGICAL TRANSFORMATION [J].
BERTOLERO, F ;
POZZI, G ;
SABBIONI, E ;
SAFFIOTTI, U .
CARCINOGENESIS, 1987, 8 (06) :803-808
[9]  
BLANCATO JN, 1993, HLTH RISK ASSESSMENT, P31
[10]  
BOYCE ST, 1983, IN VITRO MODELS CANC, V3, P245